Gov. Eric Holcomb said Clay Robbins' "humble service to our great state truly represents the very best of what it means to be ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

The market didn't appreciate Amgen's (NASDAQ: AMGN) latest clinical data update, with the biopharma's shares falling more ...

After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its ...

American drugmaker Eli Lilly and Company's India unit is set to see a leadership change with managing director ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...

New Barcelona site to help drive global expansion of QIAstat-Dx as QIAGEN expands local presence with multi-year investment ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

CFO to depart at year-end in move that comes after CEO exited in September WW International Inc., the company known as ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...